Skip to content

Clinical efficacy and mechanism of Intermittent theta burst stimulation combined with working memory training for negative symptoms in schizophrenia

Clinical efficacy and mechanism of Intermittent theta burst stimulation combined with working memory training for negative symptoms in schizophrenia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088587
Enrollment
Unknown
Registered
2024-08-21
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

Working memory training group:Working memory training+Sham Intermittent theta burst stimulation treatment + Routine clinical interventions
Control group:Sham Intermittent theta burst stimulation treatment + Routine clinical interventions
Intermittent theta burst stimulation and work memory group :Intermittent theta burst stimulation and Work memory training + Routine clinical interventions

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-55 years old; 2. Conforming to the diagnostic criteria for schizophrenia in the fifth edition of the Diagnostic and Statistical Manual for Mental Disorders, diagnosed by a psychiatrist based on MINI plus v 5.0, with a course of at least 1 year; 3. Patients who have received stable dose medication in the past month and have significant negative symptoms: the negative symptom score on the Positive and Negative Symptom Scale (PANSS) is not less than 20, and at least one item on the PANSS negative symptom scale is >= 4 points; 4. All patients have stable clinical conditions and are able to provide informed consent, and all participants have obtained written informed consent; 5. Take second-generation antipsychotic drugs, such as Olanzapine and Quetiapine.

Exclusion criteria

Exclusion criteria: 1. Merge with other brain diseases; 2. Severe physical conditions, including severe liver, kidney, cardiovascular and other diseases; 3. History of alcohol and drug abuse; 4. Individual or family medical history of other mental diseases, including Personality disorder and mental retardation; 5. People with metal clips, plates, or any other metal objects on their heads; 6. Receiving electroconvulsive treatment within 6 months; 7. The evaluation process do not cooperate.

Design outcomes

Primary

MeasureTime frame
Psychopathological status;Negative symptoms ;Brain function;

Secondary

MeasureTime frame
Cognitive function;Emotional state;Social function;

Countries

China

Contacts

Public ContactZhang Wei

West China Hospital, Sichuan University

weizhang27@163.com+86 151 9664 0746

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026